Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Non-invasive fetal RHD genotyping: Validation of the method with 200 patients].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine - 1 Mar 2014

Guinchard E, Bricca P, Monnier S, Rigal D

Abstract excerpt

BACKGROUND: Non-invasive fetal RHD genotyping is an important tool to assess the risk of fetuse's hemolytic disease of anti-D allo-immunized pregnant woman by non-invasive method. A method of genotyping has been developed in the laboratory of Lyon-GHE according to Minon's team (J Gynecol Obstet Biol Reprod 2005): exon 4, 5, and 10 are amplified by real time PCR. At first, genotyping results of 200 pregnant women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetus
Share to RHD gene
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Source

Identifiers

PMID: 24559796
DOI: 10.1016/j.tracli.2013.12.001

Genes

RHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Non-invasive fetal RHD genotyping: Validation of the method with 200 patients].PMID 24559796Read ↗

[Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].Semantic proximity Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

Screening of RHD fetal genotype in RhD negative women.Semantic proximity Read ↗

[Prenatal determination of fetal RHD in maternal plasma: two-years experience of routine clinical use].Semantic proximity Read ↗

[Fetal D gene in maternal plasma should be examined in all immunized Rh(-) pregnant women to avoid invasive procedures].Semantic proximity Read ↗

[Genetic analysis of the fetus using maternal blood].Semantic proximity Read ↗

Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.Semantic proximity Read ↗

[Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.Semantic proximity Read ↗

Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.Semantic proximity Read ↗

[RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible].Semantic proximity Read ↗

Noninvasive approach for the management of hemolytic disease of the fetus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.